Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,806
Closed -$1.09M 1713
2026
Q1
$1.09M Hold
19,806
0.01% 1008
2025
Q4
$944K Sell
19,806
-1,575
-7% -$73.5K 0.01% 1111
2025
Q3
$923K Sell
21,381
-4,300
-17% -$168K 0.01% 1147
2025
Q2
$986K Buy
25,681
+1,875
+8% +$71.6K 0.01% 1130
2025
Q1
$922K Hold
23,806
0.01% 1152
2024
Q4
$805K Sell
23,806
-7,509
-24% -$270K 0.01% 1274
2024
Q3
$1.28M Sell
31,315
-1,931
-6% -$79K 0.01% 1025
2024
Q2
$1.28M Sell
33,246
-3,010
-8% -$127K 0.01% 990
2024
Q1
$1.55M Hold
36,256
0.02% 943
2023
Q4
$1.34M Buy
36,256
+2,555
+8% +$91.7K 0.02% 1059
2023
Q3
$1.22M Sell
33,701
-525
-2% -$18.6K 0.02% 1033
2023
Q2
$1.22M Buy
34,226
+79
+0.2% +$2.83K 0.01% 1051
2023
Q1
$1.21M Buy
34,147
+160
+0.5% +$5.6K 0.02% 1050
2022
Q4
$1.19M Hold
33,987
0.02% 1075
2022
Q3
$1M Buy
33,987
+909
+3% +$34.5K 0.01% 1188
2022
Q2
$1.8M Buy
33,078
+1,900
+6% +$105K 0.02% 888
2022
Q1
$1.7M Hold
31,178
0.02% 1051
2021
Q4
$1.72M Buy
+31,178
New +$1.62M 0.02% 1088

Other funds holding GSK

Yousif Capital Management's GSK Position: Q2 2026 in Review

Yousif Capital Management sold out of GSK (GSK) in Q2 2026, closing a stake of 19,806 shares — an estimated $1.09M sold.

Yousif Capital Management first reported a position in GSK in Q4 2021 and held it in 18 quarters. The position peaked at $1.8M in Q2 2022. 235 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Yousif Capital Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Yousif Capital Management sold 19,806 GSK shares in Q2 2026, an estimated $1.09M.
  • Yousif Capital Management first reported a position in GSK in Q4 2021 and held it in 18 quarters.
  • Yousif Capital Management's GSK position peaked at $1.8M in Q2 2022.
  • 235 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.